Amryt Pharma PLC Sponsored ADR Debt to Equity Ratio 2021-2022 | AMYT
Current and historical debt to equity ratio values for Amryt Pharma PLC Sponsored ADR (AMYT) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Amryt Pharma PLC Sponsored ADR debt/equity for the three months ending September 30, 2022 was .
| Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2022-09-30 | $0.41B | $0.32B | 1.27 |
| 2022-06-30 | $0.42B | $0.34B | 1.24 |
| 2022-03-31 | $0.44B | $0.35B | 1.27 |
| 2021-12-31 | $0.46B | $0.36B | 1.27 |
| 2021-09-30 | $0.55B | $0.31B | 1.80 |
| 2021-06-30 | $0.48B | $0.05B | 9.82 |
| 2021-03-31 | $0.47B | $0.05B | 8.60 |
| 2020-12-31 | $0.47B | $0.07B | 7.11 |
| 2020-09-30 | $0.00B | 0.00 | |
| 2020-06-30 | $0.00B | 0.00 | |
| 2020-03-31 | $0.00B | 0.00 | |
